DBS in the treatment of Parkinson’s disease
DOI:
https://doi.org/10.12775/QS.2024.31.55864Keywords
Parkinson's disease, Deep Brain Stimulation, Motor symptoms, Quality of life, Non-motor symptoms, Surgery, New therapyAbstract
Purpose of the Study: This review examines the role of Deep Brain Stimulation (DBS) as a therapeutic intervention for advanced PD, focusing on indications, patient selection criteria, and potential complications. Materials and Methods: A comprehensive literature review was conducted, analyzing 37 studies from the PubMed database (English-language, up to October 2024) that assess the efficacy, safety, and long-term outcomes of DBS in managing advanced PD symptoms. Basic results: DBS has proven effective in enhancing motor function and quality of life in advanced PD cases. Although generally safe, DBS can present risks, including infections, dyskinesia, and psychiatric side effects. Conclusions: DBS is well known and constantly improving technology. Appropriate patient selection is essential; DBS is generally reserved for patients meeting specific criteria, including a confirmed PD diagnosis, disease duration of more than four years, a positive response to levodopa, and the absence of severe cognitive or unmanaged psychiatric disorders. Emerging research on genetic factors may enhance patient selection in the future.
References
Kalia LV, Lang AE. Parkinson's disease. Lancet. 2015 Aug 29;386(9996):896-912. doi: 10.1016/S0140-6736(14)61393-3. Epub 2015 Apr 19
Kam TI, Hinkle JT, Dawson TM, Dawson VL. Microglia and astrocyte dysfunction in Parkinson's disease. Neurobiol Dis. 2020 Oct;144:105028. doi: 10.1016/j.nbd.2020.105028. Epub 2020 Jul 28
Kam TI, Hinkle JT, Dawson TM, Dawson VL. Microglia and astrocyte dysfunction in Parkinson's disease. Neurobiol Dis. 2020 Oct
Sveinbjornsdottir S. The clinical symptoms of Parkinson's disease. J Neurochem. 2016 Oct;139 Suppl 1:318-324. doi: 10.1111/jnc.13691. Epub 2016 Jul 11
Zafar S, Yaddanapudi SS. Parkinson Disease. [Updated 2023 Aug 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. PMID: 29261972.
Fang JY, Tolleson C. The role of deep brain stimulation in Parkinson's disease: an overview and update on new developments. Neuropsychiatr Dis Treat. 2017 Mar 7;13:723-732. doi: 10.2147/NDT.S113998.
MacMahon Copas AN, McComish SF, Fletcher JM, Caldwell MA. The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes? Front Neurol. 2021 May 26. doi: 10.3389/fneur.2021.666737.
Jankovic JParkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):368-76. doi: 10.1136/jnnp.2007.131045. PMID: 18344392.
Lee DJ, Dallapiazza RF, De Vloo P, Lozano AM. Current surgical treatments for Parkinson's disease and potential therapeutic targets. Neural Regen Res. 2018 Aug;13(8):1342-1345. doi: 10.4103/1673-5374.235220.
Krauss JK, Lipsman N, Aziz T, Boutet A, Brown P, Chang JW, Davidson B, Grill WM, Hariz MI, Horn A, Schulder M, Mammis A, Tass PA, Volkmann J, Lozano AM. Technology of deep brain stimulation: current status and future directions. Nat Rev Neurol. 2021 Feb
Nicoló G. Pozzi, Ioannis U. Isaias,Chapter 19 - Adaptive deep brain stimulation: Retuning Parkinson's disease,Editor(s): Angelo Quartarone, Maria Felice Ghilardi, François Boller,Handbook of Clinical Neurology, Elsevier, Volume 184, 2022, Pages 273-284
Rahimpour S, Kiyani M, Hodges SE, Turner DA. Deep brain stimulation and electromagnetic interference. Clin Neurol Neurosurg. 2021 Apr;203:106577. doi: 10.1016/j.clineuro.2021.106577. Epub 2021 Feb 25
Hariz M, Blomstedt P. Deep brain stimulation for Parkinson's disease. J Intern Med. 2022 Nov;292(5):764-778. doi: 10.1111/joim.13541. Epub 2022 Jul 13
Brand G, Bontempi C, Jacquot L. Impact of deep brain stimulation (DBS) on olfaction in Parkinson's disease: Clinical features and functional hypotheses. Rev Neurol (Paris). 2023 Nov
França C, Carra RB, Diniz JM, Munhoz RP, Cury RG. Deep brain stimulation in Parkinson's disease: state of the art and future perspectives. Arq Neuropsiquiatr. 2022 May
Pei H, Wu Z, Ma L, Wang J, Li J, Geng X, Zou Y, Zhang M, Qi R, Yu H. Deep Brain Stimulation Mechanisms in Parkinson's Disease: Immediate and Long-Term Effects. J Integr Neurosci. 2024 Jun 13
Doshi, Paresh K. Expanding indications for deep brain stimulation. Neurology India 66(Suppl 1):p S102-S112, Mar–Apr 2018. | DOI: 10.4103/0028-3886.226450
Barbosa, R.M.G.; Soares, M.C.; Portela, D.M.M.C.; Guimarães, T.G.; Cury, R.G. New Perspectives of Deep Brain Stimulation Indications for Parkinson’s Disease: A Critical Review. Brain Sci. 2024, 14, 638. https://doi.org/10.3390/brainsci14070638
Miguel Lopez-Cuina, Pierre-Olivier Fernagut, Marie-Hélène Canron, Anne Vital, Béatrice Lannes, André Maues De Paula, Nathalie Streichenberger, Dominique Guehl, Philippe Damier, Alexandre Eusebio, Jean-Luc Houeto, François Tison, Christine Tranchant, François Viallet, Tatiana Witjas, Stéphane Thobois, Wassilios G. Meissner,Deep brain stimulation does not enhance neuroinflammation in multiple system atrophy, Neurobiology of Disease, Volume 118, 2018, Pages 155-160, ISSN 0969-9961
Artusi, C.A.; Lopiano, L.; Morgante, F. Deep Brain Stimulation Selection Criteria for Parkinson’s Disease: Time to Go beyond CAPSIT-PD. J. Clin. Med. 2020, 9, 3931. https://doi.org/10.3390/jcm9123931
Groiss SJ, Wojtecki L, Südmeyer M, Schnitzler A. Deep brain stimulation in Parkinson's disease. Ther Adv Neurol Disord. 2009 Nov
Sara Bandres-Ciga, Monica Diez-Fairen, Jonggeol Jeff Kim, Andrew B. Singleton,Genetics of Parkinson's disease: An introspection of its journey towards precision medicine, Neurobiology of Disease, Volume 137, 2020, 104782, ISSN 0969-9961
Artusi, C.A.; Lopiano, L.; Morgante, F. Deep Brain Stimulation Selection Criteria for Parkinson’s Disease: Time to Go beyond CAPSIT-PD. J. Clin. Med. 2020, 9, 3931. https://doi.org/10.3390/jcm9123931
nternational Parkinson and Movement Disorder Society. Clinical Outcome Assessments https://www.movementdisorders.org/MDS/MDS-Clinical-Outcome-Assessment.htm (Access 10.10.2024)
Artusi CA, Romagnolo A, Imbalzano G, Montanaro E, Zibetti M, Rizzone MG, Lopiano L. Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum. Parkinsonism Relat Disord. 2021 May;86:5-9. doi: 10.1016/j.parkreldis.2021.03.017. Epub 2021 Mar 28
Bouça-Machado R, Fernandes A, Ranzato C, Beneby D, Nzwalo H, Ferreira JJ. Measurement tools to assess activities of daily living in patients with Parkinson's disease: A systematic review. Front Neurosci. 2022 Jul 20;16:945398
Hacker ML, Turchan M, Heusinkveld LE, Currie AD, Millan SH, Molinari AL, Konrad PE, Davis TL, Phibbs FT, Hedera P, Cannard KR, Wang L, Charles D. Deep brain stimulation in early-stage Parkinson disease: Five-year outcomes. Neurology. 2020 Jul 28
H acker ML, Tramontana MG, Pazira K, Meystedt JC, Turchan M, Harper KA, Fan R, Ye F, Davis TL, Konrad PE, Charles D. Long-term neuropsychological outcomes of deep brain stimulation in early-stage Parkinson's disease. Parkinsonism Relat Disord. 2023 Aug;113:105479. doi: 10.1016/j.parkreldis.2023.105479. Epub 2023 Jun 15
Hacker ML, DeLong MR, Turchan M, Heusinkveld LE, Ostrem JL, Molinari AL, Currie AD, Konrad PE, Davis TL, Phibbs FT, Hedera P, Cannard KR, Drye LT, Sternberg AL, Shade DM, Tonascia J, Charles D. Effects of deep brain stimulation on rest tremor progression in early stage Parkinson disease. Neurology. 2018 Jul 31
Carolin Semmler, Vasilija Stopic, Stefanie T. Jost, Gereon R. Fink, Peter H. Weiss, Michael T. Barbe, Preoperative motor deficits and depressive symptoms predict quality of life in patients with Parkinson’s disease at different time points after surgery for subthalamic stimulation: a retrospective study, Neurological Research and Practice, 10.1186/s42466-023-00303-2, 6, 1, (2024)
Weidong Wu, Shun Gong, Shimiao Wang, Wei Lei, Lijia Yuan, Wei Wu, Jiqing Qiu, Weijin Sun, Guoming Luan, Minwei Zhu, Xudong Wang, Guobiao Liang, Yingqun Tao, Safety and efficiency of deep brain stimulation in the elderly patients with Parkinson's disease, CNS Neuroscience & Therapeutics, 10.1111/cns.14899, 30, 8, (2024)
Ward M, Ahmed M, Markosian C, Ezike JZ, Agrawal R, Randhawa K, Liang Z, Abraham M, Paskhover B, Mammis A. Complications associated with deep brain stimulation for Parkinson's disease: a MAUDE study. Br J Neurosurg. 2021 Oct;35(5):625-628. doi: 10.1080/02688697.2021.1935727. Epub 2021 Jun 20
Eiamcharoenwit J, Akavipat P. Incidence of complications associated with deep brain stimulation surgery in patients with Parkinson's disease: An 8-year retrospective study. Saudi J Anaesth. 2024 Jan-Mar;18(1):62-69. doi: 10.4103/sja.sja_384_23. Epub 2024 Jan 2
Syed NM, Bertoni J, Bhatti DE. Deep brain stimulation for Parkinson's disease in Pakistan: Current status, opportunities and challenges. J Pak Med Assoc. 2020 Dec
Wu W, Gong S, Wang S, Lei W, Yuan L, Wu W, Qiu J, Sun W, Luan G, Zhu M, Wang X, Liang G, Tao Y. Safety and efficiency of deep brain stimulation in the elderly patients with Parkinson's disease. CNS Neurosci Ther. 2024 Aug
Lange, M., Mauerer, J., Schlaier, J. et al. Underutilization of deep brain stimulation for Parkinson’s disease? A survey on possible clinical reasons. Acta Neurochir 159, 771–778 (2017)
Lachenmayer, M.L., Mürset, M., Antih, N. et al. Subthalamic and pallidal deep brain stimulation for Parkinson’s disease—meta-analysis of outcomes. npj Parkinsons Dis. 7, 77 (2021)
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Olga Szeidl, Joanna Szydziak, Aleksandra Hrapkowicz, Kinga Janowska, Dominika Rehan, Julia Wołoszczak, Agnieszka Mioskowska, Daria Dąbkowska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 108
Number of citations: 0
